Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation

Cited by (546)

Items 101–200 of 546

1. Systemic dysregulation of the gut microenvironment plays a pivotal role in the onset and progression of inflammatory bowel disease
   Ruilong Kou, Yonggang Guo, Zhiwei Qin, Xiaochen Xu, Yihao Liu, Wenqin Wei, Yu Chen, Zhiyuan Jian, Bin Lan · 2025 · Frontiers in Immunology
2. Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness
   Daniel So, Eamonn M.M. Quigley, Kevin Whelan · 2023 · Current Opinion in Gastroenterology
3. Safety and efficacy of phage application in bacterial decolonisation: a systematic review
   Qingqing Fang, Xin Yin, Yanling He, Yan Feng, Linwan Zhang, Huan Luo, Geng Yin, Alan McNally, Zhiyong Zong · 2024 · The Lancet Microbe
4. Phage therapy for Klebsiella pneumoniae: Understanding bacteria–phage interactions for therapeutic innovations
   Julie Le Bris, Nathalie Chen, Adeline Supandy, Olaya Rendueles, Daria Van Tyne · 2025 · PLoS Pathogens
5. Colonic Transendoscopic Enteral Tubing Is a New Pathway to Microbial Therapy, Colonic Drainage, and Host–Microbiota Interaction Research
   Weihong Wang, Gaochen Lu, Xia Wu, Quan Wen, Faming Zhang · 2023 · Journal of Clinical Medicine
6. Therapeutic Phage Monitoring: A Review
   Kiran Bosco, Stephanie A. Lynch, Indy Sandaradura, Ameneh Khatami · 2023 · Clinical Infectious Diseases
7. The Future of Microbiome Therapeutics
   Milena Pitashny, Inbar Kesten, Dima Shlon, Dana Ben Hur, Haggai Bar‐Yoseph · 2025 · Drugs
8. Dynamic network modeling of gut microbiota during Alzheimer’s disease progression in mice
   Yinhu Li, Yijing Chen, Yingying Fan, Yuewen Chen, Yu Chen · 2023 · Gut Microbes
9. Gut microbes and host behavior: The forgotten members of the gut-microbiome
   Ariel Weiner, Sondra Turjeman, Omry Koren · 2023 · Neuropharmacology
10. Microbiota-directed biotherapeutics: considerations for quality and functional assessment
    Emily E.F. Fekete, Daniel Figeys, Xu Zhang · 2023 · Gut Microbes
11. Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV‐Infected Patients
    Zhaoyi Pan, Nanping Wu, Changzhong Jin · 2023 · Canadian Journal of Infectious Diseases and Medical Microbiology
12. The gut microbiome in systemic lupus erythematosus: lessons from rheumatic fever
    Gregg J. Silverman, Doua F. Azzouz, Nicolas Gisch, Abhimanyu Amarnani · 2024 · Nature Reviews Rheumatology
13. The Role of Gut Microbiota in Gastrointestinal Immune Homeostasis and Inflammation: Implications for Inflammatory Bowel Disease
    Elisabetta Bretto, Gian Paolo Caviglia, Giorgio Maria Saracco, Elisabetta Bugianesi, Davide Giuseppe Ribaldone · 2025 · Biomedicines
14. Microbiome influencers of checkpoint blockade–associated toxicity
    Yinghong Wang, Robert R. Jenq, Jennifer Ann Wargo, Stephanie S. Watowich · 2023 · The Journal of Experimental Medicine
15. Phage lysins for intestinal microbiome modulation: current challenges and enabling techniques
    Iris Pottie, Roberto Vázquez, Tom Van de Wiele, Yves Briers · 2024 · Gut Microbes
16. Gut Microbiome Signature in Predisease Phase of Inflammatory Bowel Disease: Prediction to Pathogenesis to Prevention
    Williams Turpin, Sun-Ho Lee, Kenneth Croitoru · 2025 · Gastroenterology
17. A meta-analysis of the gut microbiome in inflammatory bowel disease patients identifies disease-associated small molecules
    Moamen M. Elmassry, Kohei Sugihara, Pranatchareeya Chankhamjon, Yeji Kim, Francine R. Camacho, Shuo Wang, Yuki Sugimoto, Seema Chatterjee, Lea Ann Chen, Nobuhiko Kamada et al. · 2025 · Cell Host & Microbe
18. Microbiome-active drug delivery systems (MADDS): Leveraging microbial stimuli for controlled drug release
    Srinivas Kamath, Amin Ariaee, Amer Abdelhafez, Zarnab Asif, Nicole S.L. Chan, Kate Collins, Alexander Hunter, Paul Joyce · 2025 · Advanced Drug Delivery Reviews
19. 5S-Heudelotinone alleviates experimental colitis by shaping the immune system and enhancing the intestinal barrier in a gut microbiota-dependent manner
    Qing Meng, Jianshuang Guo, Ke Lv, Yang Liu, Jin Zhang, Mingyue Li, Xirui Cheng, Shenghua Chen, Xiaoguang Huo, Quan Zhang et al. · 2024 · Acta Pharmaceutica Sinica B
20. Host–pathobiont interactions in Crohn’s disease
    Roberta Caruso, Bernard C. Lo, Grace Chen, Gabriel Núñez · 2024 · Nature Reviews Gastroenterology & Hepatology
21. Sea Buckthorn Polysaccharide Ameliorates Colitis
    Qinqin Ouyang, Xin Li, Yongheng Liang, Rong Liu · 2024 · Nutrients
22. Therapeutic Prospects of Mesenchymal Stem Cell and Their Derived Exosomes in the Regulation of the Gut Microbiota in Inflammatory Bowel Disease
    Yaru Qiao, Xiaohua Tang, Ziyue Liu, Dickson Kofi Wiredu Ocansey, Mengjiao Zhou, Anquan Shang, Fei Mao · 2024 · Pharmaceuticals
23. Intestinal dysbiosis and colorectal cancer
    Zi‐Ran Kang, Shanshan Jiang, Jing‐Yuan Fang, Huimin Chen · 2025 · Chinese Medical Journal
24. A Mammalian Cell's Guide on How to Process a Bacteriophage
    Leo Kan, Jeremy J. Barr · 2023 · Annual Review of Virology
25. Human microbiome research: Growing pains and future promises
    Jens Puschhof, Eran Elinav · 2023 · PLoS Biology
26. Targeting the gut microbiota in inflammatory bowel diseases: where are we?
    Nicolas Benech, Harry Sokol · 2023 · Current Opinion in Microbiology
27. A novel phage carrying capsule depolymerase effectively relieves pneumonia caused by multidrug-resistant Klebsiella aerogenes
    Xiaohu Cui, Bing Du, Junxia Feng, Yanling Feng, Zheng Fan, Jinfeng Chen, Jinghua Cui, Lin Gan, Tongtong Fu, Ziyan Tian et al. · 2023 · Journal of Biomedical Science
28. From ASCA breakthrough in Crohn's disease and Candida albicans research to thirty years of investigations about their meaning in human health
    Boualem Sendid, Marjorie Cornu, Camille Cordier, Julie Maria Jozefa Bouckaert, Jean‐Frédéric Colombel, Daniel Poulain · 2023 · Autoimmunity Reviews
29. Gut‑liver axis in liver disease: From basic science to clinical treatment (Review)
    Jianpeng Wang, Xinyi Wang, Enba Zhuo, Bangjie Chen, Shixin Chan · 2024 · Molecular Medicine Reports
30. Recent insights on challenges encountered with phage therapy against gastrointestinal-associated infections
    Reem A. Youssef, Masarra M. Sakr, Rania Ibrahim Shebl, Khaled M. Aboshanab · 2025 · Gut Pathogens
31. Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses
    Nicolas Vallet, Maud Salmona, Jeanne Malet-Villemagne, Maxime Bredel, Louise Bondeelle, Simon Tournier, Séverine Mercier‐Delarue, S. Cassonnet, Brian O. Ingram, Régis Peffault de Latour et al. · 2023 · Cell Host & Microbe
32. Engaging natural antibody responses for the treatment of inflammatory bowel disease via phosphorylcholine-presenting nanofibres
    Elizabeth J. Curvino, Emily F. Roe, Helena Freire Haddad, Alexa R. Anderson, Mia E. Woodruff, Nicole L. Votaw, Tatiana Segura, Laura P. Hale, Joel H. Collier · 2023 · Nature Biomedical Engineering
33. Phage therapy in noncommunicable diseases
    Denise Kviatcovsky, Rafael Valdés‐Mas, Sara Federici, Eran Elinav · 2023 · Science
34. Vaccine-enhanced competition permits rational bacterial strain replacement in the gut
    Verena Lentsch, Aurore Woller, Andrea Rocker, Selma Aslani, Claudia Moresi, Niina Ruoho, Louise Larsson, Stefan A. Fattinger, Nicolas Wenner, Elisa Cappio Barazzone et al. · 2025 · Science
35. Orchestrating Gut Disorders by Oral Delivery of a Living-Synthetic Hybrid Hydrogel.
    Kun Zhang, Yi Liang, Qiao Chen, Shirong Zhang, Yanbin Liu, Wei Wu, Li Zhu, Kai Qu, Xian Qin, Yi-Dan Chen et al. · 2025 · ACS Nano
36. From dysbiosis to longevity: a narrative review into the gut microbiome’s impact on aging
    Ching‐Hung Tseng, Chun‐Ying Wu · 2025 · Journal of Biomedical Science
37. Ectopic colonization by oral bacteria as an emerging theme in health and disease
    Carla Hernández‐Cabanyero, Pascale Vonaesch · 2024 · FEMS Microbiology Reviews
38. Mouse adaptation of human inflammatory bowel diseases microbiota enhances colonization efficiency and alters microbiome aggressiveness depending on the recipient colonic inflammatory environment
    Simon M. Gray, Anh D. Moss, Jeremy Herzog, Saori Kashiwagi, Bo Liu, Jacqueline B. Young, Shan Sun, Aadra Prashant Bhatt, Anthony A. Fodor, Ryan Balfour Sartor · 2024 · Microbiome
39. Mechanisms by which microbiome-derived metabolites exert their impacts on neurodegeneration
    Lara Kern, Ignacio Mastandrea, Anna Melekhova, Eran Elinav · 2024 · Cell chemical biology
40. Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools
    Marco Murgiano, Bianca Bartocci, Pierluigi Puca, Federica Di Vincenzo, Angelo DEL GAUDIO, Alfredo Papa, Giovanni Cammarota, Antonio Gasbarrini, Franco Scaldaferri, Loris Riccardo Lopetuso · 2025 · International Journal of Molecular Sciences
41. From Microbial Homeostasis to Systemic Pathogenesis: A Narrative Review on Gut Flora’s Role in Neuropsychiatric, Metabolic, and Cancer Disorders
    Xili Yan, Liangbin Shi, Xiu-Ling Zhu, Yingdi Zhao, Jie Luo, Qiang Li, Zhiliang Xu, Jian Jun Zhao · 2025 · Journal of Inflammation Research
42. Large-scale genomic survey with deep learning-based method reveals strain-level phage specificity determinants
    Yi‐Yan Yang, Keith Dufault‐Thompson, Wei Yan, Tian Cai, Lei Xie, Xiaofang Jiang · 2024 · GigaScience
43. Advances and optimization strategies in bacteriophage therapy for treating inflammatory bowel disease
    Li Yang, Xiao-meng Li, Hao-yu Duan, Kaidi Yang, Junfeng Ye · 2024 · Frontiers in Immunology
44. Enhancing phage therapy by coating single bacteriophage-infected bacteria with polymer to preserve phage vitality
    Sisi Lin, Guocheng Xie, Jun He, Lu Meng, Yan Pang, Jinyao Liu · 2025 · Nature Biomedical Engineering
45. The role of the gut microbiome and its metabolites in cerebrovascular diseases
    Hongyu Xu, Ziyue Xu, Shengrong Long, Zhengwei Li, Jiazhi Jiang, Qiangqiang Zhou, Xiaopeng Huang, Xiaohui Wu, Wei Wei, Xiang Li · 2023 · Frontiers in Microbiology
46. Glucose Induces Resistance to Polymyxins in High-Alcohol-Producing Klebsiella pneumoniae via Increasing Capsular Polysaccharide and Maintaining Intracellular ATP
    Zheng Fan, Tongtong Fu, Hongbo Liu, Zhoufei Li, Bing Du, Xiaohu Cui, Rui Zhang, Yanling Feng, Hanqing Zhao, Guanhua Xue et al. · 2023 · Microbiology Spectrum
47. The phageome in normal and inflamed human skin
    Matthias Wielscher, Karin Pfisterer, David Samardzic, Parvaneh Balsini, Christine Bangert, Karin Jäger, Maria Buchberger, Brigitte Selitsch, Petra Pjevac, Birgit Willinger et al. · 2023 · Science Advances
48. Recent advances in anti-inflammatory active components and action mechanisms of natural medicines
    Zhimin Wu, Tao Zhang, Xiaofei Ma, Shuai Guo, Qingqing Zhou, Arshad Zahoor, Ganzhen Deng · 2023 · Inflammopharmacology
49. Prospects and Challenges of Bacteriophage Substitution for Antibiotics in Livestock and Poultry Production
    Aoyu Jiang, Zixin Liu, Xiaokang Lv, Chuanshe Zhou, Tao Ran, Zhiliang Tan · 2024 · Biology
50. The Microbiome in Inflammatory Bowel Disease
    Aranzazu Jauregui-Amezaga, Annemieke Smet · 2024 · Journal of Clinical Medicine
51. Ginsenoside Rb1 Alleviates DSS-Induced Ulcerative Colitis by Protecting the Intestinal Barrier Through the Signal Network of VDR, PPARγ and NF-κB
    Yi Zhou, Xinyu Xiong, Zhe Cheng, Zekai Chen, Shizhen Wu, Yan Yu, Yujin Liu, Guang Chen, Lingli Li · 2024 · Drug Design Development and Therapy
52. Advancing Inflammatory Bowel Disease Treatment by Targeting the Innate Immune System and Precision Drug Delivery
    Kat F. Kiilerich, Trine Andresen, Behrooz Darbani, Laura Gregersen, Anette Liljensøe, Tue Bjerg Bennike, René Holm, Jesper Bonnet Moeller, Vibeke Charlotte Andersen · 2025 · International Journal of Molecular Sciences
53. Evaluating the anti-inflammatory and antioxidant efficacy of complementary and alternative medicines (CAM) used for management of inflammatory bowel disease: a comprehensive review
    Sia Shin, Siqi Chen, Kangzhe Xie, Suehad Abou Duhun, Tamara Ortíz · 2025 · Redox Report
54. Phage therapy for Clostridioides difficile infection
    Kosuke Fujimoto, Satoshi Uematsu · 2022 · Frontiers in Immunology
55. From microbial technology to microbiota medicine as a clinical discipline: Sustainable development goal
    Faming Zhang, Weihong Wang, Yongzhan Nie, Jingnan Li, Xing‐Xiang He · 2023 · Microbial Biotechnology
56. Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference
    Loris Riccardo Lopetuso, S Deleu, Pierluigi Puca, Maria Teresa Abreu, Alessandro Armuzzi, Giovanni Barbara, Flavio Caprioli, Siew C. Ng, Samuel Paul Costello, Andrea Damiani et al. · 2025 · Inflammatory Bowel Diseases
57. The impact of the human gut microbiome on the treatment of autoimmune disease
    Renuka R. Nayak, Diego A. Orellana · 2024 · Immunological Reviews
58. The potential of EGCG in modulating the oral-gut axis microbiota for treating inflammatory bowel disease
    Jiaming Ge, Mengyuan Li, Jingwen Yao, Jinling Guo, Xiankuan Li, Gang Li, Xiangli Han, Zheng Li, Ming Liu, Jing Zhao · 2024 · Phytomedicine
59. The gut virome in association with the bacteriome in gastrointestinal diseases and beyond: roles, mechanisms, and clinical applications
    Zhiyang Feng, Elke Burgermeister, Anna Philips, Tao Zuo, Weijie Wen · 2025 · Precision Clinical Medicine
60. Effective of phage cocktail against Klebsiella pneumoniae infection of murine mammary glands
    Bingchun Liang, Bo Han, Yuxiang Shi, Xiaoping Li, Wenpeng Zhao, John Patrick Kastelic, Jian Gao · 2023 · Microbial Pathogenesis
61. Oral pathobiont Klebsiella chaperon usher pili provide site-specific adaptation for the inflamed gut mucosa
    Yijie Guo, Sho Kitamoto, Gustavo G. Caballero-Flores, Yeji Kim, Daisuke Watanabe, Kohei Sugihara, Gabriel Núñez, Christopher J. Alteri, Naohiro Inohara, Nobuhiko Kamada · 2024 · Gut Microbes
62. Phage-mediated virulence loss and antimicrobial susceptibility in carbapenem-resistant Klebsiella pneumoniae
    Yanshuang Yu, Mengzhu Wang, Liuying Ju, Minchun Li, Mengshi Zhao, Hui Deng, Christopher Rensing, Qiue Yang, Shungui Zhou · 2024 · mBio
63. Gut microbiome associated dysbiosis: Limited regimens and expanding horizons of phage therapy
    Biplab Singha, Bhupendra Singh Rawat, Ramya Venkataraman, Tripti Nair, Eric H. Rosenn, Vijay Soni · 2023 · Aspects of Molecular Medicine
64. Bacteriophage as a potential biotherapeutics to combat present-day crisis of multi-drug resistant pathogens
    Ananya Pattnaik, Sanghamitra Pati, Sangram Keshari Samal · 2024 · Heliyon
65. Fecal Microbiota Transplantation: Indications, Methods, and Challenges
    Jee Young Lee, Yehwon Kim, Jiyoun Kim, Jiyeun Kate Kim · 2024 · The Journal of Microbiology
66. Bacteriophages and their potential for treatment of metabolic diseases
    Youpeng Deng, Shouwei Jiang, Hanyu Duan, Haonan Shao, Yi Duan · 2024 · Journal of Diabetes
67. Probiotic encapsulation strategies for controlled intestinal delivery and microbiome dysbiosis therapy
    Yilin You, Hongyun Lu, Di Wang, Bijie Wang, Qihe Chen, Ying Shi · 2025 · Journal of Controlled Release
68. Gut virome dynamics: from commensal to critical player in health and disease
    Luis Alberto Chica Cárdenas, Maureen M. Leonard, Megan T. Baldridge, Scott A. Handley · 2025 · Nature Reviews Gastroenterology & Hepatology
69. Kidney microbiota dysbiosis contributes to the development of hypertension
    Xinyu Liu, Jing Li, Yamei Zhang, Luyun Fan, Yanli Xia, Yong‐Yang Wu, Junru Chen, Xinyu Zhao, Qiannan Gao, Bing Xu et al. · 2022 · Gut Microbes
70. Employment of the Phage Cocktail as a Species-Specific Recognition Agent for Wide-Spectrum Detection of Bacterial Strains
    Honglin Yang, Zong Gou, Hongwei Yuan, Xin Yue, Shuguang Lu, Zhifeng Fu · 2023 · Analytical Chemistry
71. Phage therapy for bone and joint infections: A comprehensive exploration of challenges, dynamics, and therapeutic prospects
    Jiaze Peng, Caopei Guo, Chengbing Yang, Lin Zhang, Fuyin Yang, Xianpeng Huang, Yang Yu, Tao Zhang, Jiachen Peng · 2024 · Journal of Global Antimicrobial Resistance
72. Progress of tumor-resident intracellular bacteria for cancer therapy
    Peng Bao, Xian‐Zheng Zhang · 2024 · Advanced Drug Delivery Reviews
73. Gut microbiome in IBD: past, present and the future
    Jingwan Zhang, Joyce Wing Yan Mak, Siew C. Ng · 2025 · Gut
74. Bacteriophages targeting protective commensals impair resistance against Salmonella Typhimurium infection in gnotobiotic mice
    Alexandra von Strempel, Anna S. Weiß, Johannes Wittmann, Marta Salvado Silva, Diana Ring, Esther Wortmann, Thomas Clavel, Laurent Debarbieux, Karin Kleigrewe, Bärbel Stecher · 2023 · PLoS Pathogens
75. Core-shell structured nanomembrane with sequential immune and vascular isolation effects followed by chondrogenic induction to promote stable stem cell-based subcutaneous cartilage regeneration in large animals
    Gao, Erji, Wang, Ziming, Zhao, Shaohua, Zhu, Xinsheng, Xu, Songshan, Xu, Yong, Wang, Yigong, Xu, Ning, Tao, Bo · 2024 · Chemical Engineering Journal
76. Control of Bacillus cereus in rice cake and food contact surfaces with novel Becedseptimavirus genus phage BCC348 and its partial SPOR domain-containing endolysin LysBCC348
    Hanbin Seol, Byoung Sik Kim, Minsik Kim · 2024 · LWT
77. Droplet microfluidics: unveiling the hidden complexity of the human microbiome
    Yibin Xu, Zhiyi Wang, Caiming Li, Shuiquan Tian, Wenbin Du · 2025 · Lab on a Chip
78. Mucosa-associated bacteria and metabolites in inflammatory bowel disease: from inside to insight
    Xinyu Wang, LinLin He, Yue Dong, Xiali Qin, Hu Zhang, Bangmao Wang, Sinan Wang, Hailong Cao · 2026 · npj Biofilms and Microbiomes
79. Microbiota and Gut Health: Promising Prospects for Clinical Trials from Bench to Bedside
    Jie Wang, Puxuan Zhang, Shujie Chen, Huimin Duan, Liwei Xie · 2022 · Advanced Gut & Microbiome Research
80. Sugar-Phosphate Toxicities Attenuate Salmonella Fitness in the Gut
    Erin F. Boulanger, Anice Sabag-Daigle, Maryam Baniasad, Katherine Kokkinias, Andrew Schwieters, Kelly C. Wrighton, Vicki Hopper Wysocki, Brian M. M. Ahmer · 2022 · Journal of Bacteriology
81. Evolving concepts of host–pathobiont interactions in autoimmunity
    Márcia Santos Pereira, Martin Alexander Kriegel · 2022 · Current Opinion in Immunology
82. Phage-encoded carbohydrate-interacting proteins in the human gut
    Daniela Rothschild-Rodriguez, Morgen Hedges, Merve Kaplan, Sercan Karav, Franklin L. Nóbrega · 2023 · Frontiers in Microbiology
83. Cytotoxic synergism of Clostridioides difficile toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases
    Gabrio Bassotti, Alessandro Fruganti, Fabrizio Stracci, Pierfrancesco Marconi, Katia Fettucciari · 2023 · World Journal of Gastroenterology
84. The gut-liver axis in hepatobiliary diseases
    Masataka Ichikawa, Haruka Okada, Nobuhiro Nakamoto, Nobuhito Taniki, Po–Sung Chu, Takanori Kanai∥ · 2024 · Inflammation and Regeneration
85. Polyvalent bacteriophages conjugated with ROS-scavenging nanozymes enhance antibiotic-resistant biofilm disruption and anti-inflammatory therapy
    Luokai Wang, Yuexue Mai, Junzheng Zhang, Chujin Ruan, Jian Ping Hu, Kai Ye, Yan He, Dongsheng Wang, Lulu Jin, Zhengwei Mao et al. · 2025 · Chemical Engineering Journal
86. Microbiota and gastric cancer: from molecular mechanisms to therapeutic strategies
    Zhou Chen, Dacheng Jin, Jinjing Hu, Defeng Guan, Qizhou Bai, Yunjiu Gou · 2025 · Frontiers in Cellular and Infection Microbiology
87. Microbial threads in the tapestry of rheumatoid arthritis
    Jing Li, Kristine A. Kuhn · 2025 · Journal of Clinical Investigation
88. Comparative Analysis of Fecal Microbiota in Vegetarians and Omnivores
    Changbao Sun, Ang Li, Cong Xu, Jiage Ma, Huan Wang, Zhanmei Jiang, Juncai Hou · 2023 · Nutrients
89. Bacteriophage EPP-1, a potential antibiotic alternative for controlling edwardsiellosis caused by Edwardsiella piscicida while mitigating drug-resistant gene dissemination
    Ganghua Han, Ting Huang, Xinchun Liu, Ruyin Liu · 2024 · Scientific Reports
90. Physiochemically and Genetically Engineered Bacteria: Instructive Design Principles and Diverse Applications
    Xia Lin, Rong Jiao, Haowen Cui, Xuebing Yan, Kun Zhang · 2024 · Advanced Science
91. Examining alternative approaches to antibiotic utilisation: A critical evaluation of phage therapy and antimicrobial peptides combination as potential alternatives
    Chibuzo V. Alisigwe, Stanley Chibuzor Ikpa, Uchenna Joseph Otuonye · 2025 · The Microbe
92. Applications of bacteriophages in precision engineering of the human gut microbiome
    Xiaoxian Kuang, Juntao Shen, Linggang Zheng, Yi Duan, Yingfei Ma, Elaine Lai‐Han Leung, Lei Dai · 2025 · Engineering Microbiology
93. Leveraging collateral sensitivity to counteract the evolution of bacteriophage resistance in bacteria
    YongQi Mu, Yuqin Song, Xueru Tian, Zixuan Ding, Shigang Yao, Yi Li, Chao Wang, Dawei Wei, Waldemar Vollmer, Gang Zhang et al. · 2025 · mLife
94. Current Clinical Laboratory Challenges to Widespread Adoption of Phage Therapy in the United States
    Ahnika Kline, Ana Georgina Cobián Güemes, Jennifer B. Yore, Chandrabali Ghose, Daria Van Tyne, Katrine Whiteson, David T. Pride · 2025 · Antibiotics
95. Emerging concepts and shifting paradigms for understanding the microbial basis of inflammatory bowel diseases
    Megan S. Kennedy, Eugene B. Chang · 2025 · Journal of Clinical Investigation
96. Combating Klebsiella pneumoniae: from antimicrobial resistance mechanisms to phage-based combination therapies
    Jiaxin Ding, Weilei Yan, Rui Zheng, Mengjie Ma, Liming Jiang · 2025 · Frontiers in Cellular and Infection Microbiology
97. The application of adaptively evolved thermostable bacteriophage ΦYMFM0293 to control Salmonella spp. in poultry skin
    Jieon Lee, Do-Yeon Kim, Minsik Kim · 2023 · Food Research International
98. Exploring the Potential of Fecal Microbiota Transplantation as a Therapy in Tuberculosis and Inflammatory Bowel Disease
    Adrian Boicean, Dan Georgian Bratu, Radu Sorin Fleacă, Gligor Vasile, Leeb Shelly, Sabrina Bîrsan, Ciprian Ionut Bacila, Adrian Gheorghe Hasegan · 2023 · Pathogens
99. The diverse roles of sphingolipids in inflammatory bowel disease
    Chelsea L. Doll, Ashley J. Snider · 2024 · The FASEB Journal
100. Gut microbiota: a crucial player in the combat against tuberculosis
     Lin Jie, Dongli Chen, Yongen Yan, Jiang Pi, Jun-Fa Xu, Lingming Chen, Biying Zheng · 2024 · Frontiers in Immunology